12 mg tirzepatide Mounjaro 12.5mg Do not inject in areas where the skin is bruised Zepbound 12.5 mg/0.5 mL injection

Not for those over 65 or with heart disease

Any marketing suggesting FDA approval or endorsement for this product is misleading

A follow-up study, assessing rectal biopsies of the patients, found that patients with the lowest 5-HT concentration in the rectum, responded the greatest to ondansetron (Gunn et al., 2019)

Complete data show tirzepatide, Lillys dual-action diabetes drug, brings greater A1C reduction, weight loss than semaglutide

Consider testing copper and zinc levels every 12 weeks, along with liver and kidney function tests

This can lead to fewer hospital visits, less reliance on cardiovascular medications, and an improved ability to stay active and engage in daily activities without fear of sudden cardiac events